Industry Coverage
Romain Leyaute
Financial Analyst
T: +33 (0)1 4770 3024
Email
Sales Contact
T: +33 1 4770 3024
Email
Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview

 

> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe

Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [861 EMAT Reports], which includes:

 

Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.

 

The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.

 

The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.

 

Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
20/04/2018 Private Group Led by Axcel Management Orion Diagnostica Finland Diagnostic Medical Equipment * 89193
03/04/2018 Fagron Humco Texas Pharmaceuticals, Biomedical Research Laboratory ** 90095
12/03/2018 Private Group led by Adolfsen Group Frösunda Omsorg Sweden Care Home, Specialist Care ** 88688
25/01/2018 Dechra Pharmaceuticals AST Farma & Le Vet Beheer Netherlands Veterinary Pharmaceuticals ** 88864
02/01/2018 La Phocéenne de Cosmétique (Le Petit Olivier) Biocos Marketing Développement (Lovea) France Personal Products * 88075
08/12/2017 Medtronic Crospon Ireland Diagnostic Medical Equipment * 88215
08/11/2017 Private Group Led by Fremont Realty Capital Porthaven Group United Kingdom Care Home * 88720
29/09/2017 Capital Care Group Anville Court United Kingdom Care Home * 88697
31/07/2017 Cantel Medical BHT Group Germany Medical Equipment ** 86166
24/07/2017 Private Group Led by KKR Nature's Bounty Co. (Formerly NBTY) United States Pharmaceuticals, Personal Products, Food Complements * 85250
10/07/2017 Eurofins Scientific Amatsigroup France Laboratory Testing Services, Biomedical Research Laboratory ** 86072
23/06/2017 Animalcare Group Ecuphar Belgium Veterinary Pharmaceuticals *** 87154
08/06/2017 Private Group Led by Intermediate Capital Group and Sagesse Retraite Sante DomusVi Group France Care Home, Specialist Care *** 87458
07/06/2017 Korian Portfolio of 8 Nursing Care and Assisted Living Facilities Belgium Care Home * 88773
17/05/2017 Private Group led by Oaktree Capital Management Vitanas Germany Care Home * 88741
04/05/2017 La Poste Asten Sante France Home Care * 84832
27/04/2017 Private Group led by IK Investment Partners Colisée Patrimoine Group France Care Home * 84373
20/04/2017 Private Group led by AGIC Capital Fotona Holdings United States Medical Equipment * 83940
06/04/2017 Private Group Led by InfraVia Capital Partners Carechoice Ireland Care Home * 84642
06/03/2017 Private Group Led by CVC Capital Partners Vitalia Home Spain Home Care * 83268
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report